Detalles de la búsqueda
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell;
184(7): 1821-1835.e16, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667349
2.
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.
Mol Ther;
31(3): 788-800, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575794
3.
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Proc Natl Acad Sci U S A;
118(36)2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417349
4.
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B).
J Med Virol;
95(7): e28923, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403896
5.
Pyroptosis: A Promising Mechanism Linking SARS-CoV-2 Infection to Adverse Pregnancy Outcomes.
Int J Mol Sci;
24(11)2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298229
6.
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.
Allergy;
77(8): 2446-2458, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403221
7.
Efficacy of mucosal vaccination using a protozoan parasite as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of LeCoVax-2, a candidate vaccine against COVID-19.
Pharmacol Res;
186: 106546, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336215
8.
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples.
J Med Virol;
92(10): 2096-2104, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383254
9.
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
J Immunol Methods;
524: 113588, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040193
10.
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.
J Clin Virol;
173: 105661, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503118
11.
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020.
Z Gesundh Wiss;
: 1-6, 2023 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36776202
12.
Rectal Administration of Leishmania Cells Elicits a Specific, Th1-Associated IgG2a Response in Mice: New Perspectives for Mucosal Vaccination against Leishmaniasis, after the Repurposing of a Study on an Anti-Viral Vaccine Candidate.
Trop Med Infect Dis;
8(8)2023 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624344
13.
Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.
Parasit Vectors;
16(1): 35, 2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703216
14.
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection.
Front Public Health;
11: 1195674, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415699
15.
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy.
Acta Trop;
248: 107042, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863379
16.
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.
Viruses;
14(7)2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891420
17.
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.
Front Public Health;
10: 847384, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35433614
18.
SARS-CoV-2 Seroconversion and Pregnancy Outcomes in a Population of Pregnant Women Recruited in Milan, Italy, between April 2020 and October 2020.
Int J Environ Res Public Health;
19(24)2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36554602
19.
Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects.
J Immunol Methods;
500: 113197, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843712
20.
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
Hum Vaccin Immunother;
18(5): 2047582, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35289714